Changes in gait pattern as assessed by the GAITRite™ walkway system in MPS II patients undergoing enzyme replacement therapy

By Wood M.   Cleary M.   Alderson L.   Vellodi A.  

Journal of Inherited Metabolic Disease, Vol. 32, Iss. 1, 2009-12 ,pp. : 127-135

Springer Publishing Company

Access to resources Recommend Favorite

Enzyme replacement therapy in Fabry disease

By Brady R.   Murray G.   Moore D.   Schiffmann R.  

Journal of Inherited Metabolic Disease, Vol. 24, Iss. 2, 2001-04 ,pp. : 18-24

Springer Publishing Company

Access to resources Recommend Favorite

Enzyme replacement therapy in two patients with an advanced severe (Hurler) phenotype of mucopolysaccharidosis I

By Tokic Visnja   Barisic Ingeborg   Huzjak Nevenka   Petkovic Giorgie   Fumic Ksenija   Paschke Eduard  

European Journal of Pediatrics, Vol. 166, Iss. 7, 2007-07 ,pp. : 727-732

Springer Publishing Company

Access to resources Recommend Favorite

IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: A case report

By Martinez-Redondo C.   Ortuño F.   Lozano M.   Jerez A.   del Mar Osma M.   Giraldo P.   Vicente V.  

Journal of Inherited Metabolic Disease, Vol. 32, Iss. 1, 2009-12 ,pp. : 265-267

Springer Publishing Company

Access to resources Recommend Favorite

Restricted upper extremity range of motion in mucopolysaccharidosis type I: no response to one year of enzyme replacement therapy

By Cox-Brinkman J.   Smeulders M.   Hollak C.   Wijburg F.  

Journal of Inherited Metabolic Disease, Vol. 30, Iss. 1, 2007-02 ,pp. : 47-50

Springer Publishing Company

Access to resources Recommend Favorite